Perioperative Follow-up Protocols for Pelvic Organ Prolapse Surgery
Launched by SAGLIK BILIMLERI UNIVERSITESI · Oct 6, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the care of women who are having surgery for pelvic organ prolapse, a condition where pelvic organs slip down and cause discomfort. The main goal is to create effective follow-up care protocols for women aged 30 to 65 after their surgery. Researchers want to find out if these follow-up practices can help improve the women’s quality of life, reduce symptoms, and address concerns related to sexual health and anxiety.
To be eligible for this study, participants need to be women between the ages of 30 and 65, who are sexually active and can read, write, and speak Turkish. They should also have a specific severity of pelvic organ prolapse (stage 2 or higher). Participants will be contacted regularly to discuss their recovery and experiences after surgery. It's important to note that the trial is not yet recruiting participants, so if you or someone you know is interested, it may be helpful to check back later for updates.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Being stage ≥2 according to POP Classification (POP-Q),
- • Being between 30-65 years old,
- • Being sexually active,
- • Ability to read and write,
- • Ability to speak Turkish,
- • Ability to use phone
- • Having a phone that can be reached at all times and
- • Agreeing to participate in the study
- Exclusion Criteria:
- • Being stage \<2 according to POP Classification (POP-Q),
- • Being between \<30 and \>65 years of age,
- • Not being sexually active,
- • Not being able to read and write,
- • Not being able to speak Turkish,
- • Inability to use the phone
- • Not having a phone that can be reached at all times and
- • Not agreeing to participate in the study
- • Discontinue the research for any reason
About Saglik Bilimleri Universitesi
Saglik Bilimleri Universitesi, or the University of Health Sciences, is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university focuses on translating scientific discoveries into practical applications that enhance patient care and public health outcomes. Its commitment to rigorous ethical standards and comprehensive training equips researchers and healthcare professionals to contribute effectively to the global medical community. Through its clinical trial initiatives, Saglik Bilimleri Universitesi aims to address pressing health challenges and foster the development of new therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Gulsah Kök
Study Director
SBU Health Science Faculty Gulhane Nursing Faculty
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported